-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster III

Symposia: Allogeneic Transplantation: Disease Response and Comparative Treatment Studies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Sachiko Seo, MD, PhD1, Junya Kanda, MD, PhD2, Kenta Kono3*, Yoshihiro Inamoto, MD4, Naoyuki Uchida, MD, PhD5, Noriko Doki6, Masatsugu Tanaka7*, Masashi Sawa, MD, PhD8*, Makoto Onizuka, MD, PhD9, Yuta Katayama, MD, PhD10, Tetsuya Eto, MD, PhD11*, Ken-ichi Matsuoka, MD, PhD12, Takahiro Fukuda4*, Takahide Ara, M.D., Ph.D.13*, Yukiyasu Ozawa14*, Toshiro Kawakita15*, Keisuke Kato, MD16, Koji Uchiyama3*, Tatsuo Ichinohe17, Yoshiko Atsuta18,19* and Fumihiko Kimura, MD, PhD20

1Dokkyo Medical University,, Tochigi, Japan
2Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Dokkyo Medical University, Tochigi, Japan
4Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
5Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan
6Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
7Department of Hematology, Kanagawa Cancer Center, Yokohama, KAN, Japan
8Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan
9Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
10Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan
11Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
12Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
13Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
14Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
15Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, KUM, Japan
16Division of Pediatric Hematology and Oncology, Ibaraki Children's Hospital, Tsukuba, Japan
17Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
18Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
19Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
20Division of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan

Madlen Jentzsch, MD1*, Lara Bischof1*, Jule Ussmann, MD1*, Donata Backhaus, MD1*, Dominic Brauer, MD1*, Klaus H. Metzeler, MD1, Marco Herling, MD1*, Maximilian Merz, MD1, Vladan Vucinic, MD1*, Georg-Nikolaus Franke, MD1*, Uwe Platzbecker, MD1* and Sebastian Schwind, MD2*

1Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
2Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Saxonia, Germany

Yishan Ye, MD1*, Myriam Labopin, MD2*, Jia Chen3*, Zafer Gulbas4*, Xi Zhang, M.D., Ph.D.5*, Yener Koc, MD6, Didier Blaise, MD, PhD7, Fabio Ciceri, MD8*, Emmanuelle Polge, M.Sc9*, Houhou Mohamad9*, Lin Li9*, Yi Luo, M.D.1*, Depei Wu10, He Huang1, Mohamad Mohty, MD PhD9,11 and Norbert Claude Gorin Sr.9

1Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
3National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China., Soochow, China
4Anadolu Medical Center, Gebze, Turkey
5Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
6Bone Marrow Transplant Unit, Medicana International Hospital Istanbul, Istanbul, Turkey
7Département d'hématologie, Programme de transplantation et de thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Aix-Marseille University, Institut Paoli Calmettes, Marseille, France
8Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
9EBMT Global Committee (Shanghai and Paris offices) and Acute Leukemia Working Party, Hopital Saint-Antoine APHP and Sorbonne University, Paris, France, Paris, France
10The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases (Suzhou), Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
11EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France

Anna Sureda1, Ariane Boumendil, PhD2*, Philipp Berning3*, Hervé Finel2*, Denis Caillot, MD4*, Wolf Roesler, M.D.5*, Jürgen Finke, MD, PhD6, Igor Wolfgang Blau, MD7*, Veronique Leblond, MD, PhD8*, Joerg Bittenbring9*, Anna Tsoulkani10*, Ben Carpenter11*, Arnon Nagler, MD12, Didier Blaise, MD, PhD13, Peter Dreger, MD14 and Norbert Schmitz, MD3*

1Hematology Department, Institut Català d'Oncologia-Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
2EBMT Lymphoma Working Party Paris Office, Paris, France
3Department of Medicine A, University Hospital Münster, Münster, Germany
4Hematology Department, Dijon University Hospital, Dijon, France
5University of Erlangen-Nuernberg - Hematology/Oncology, Erlangen, Germany
6Department of Medicine, Hematology-Oncology, University of Freiburg, Freiburg, Germany
7Dept. Hematology, Oncology and Tumorimmunology, Charité University Medicine Berlin, Berlin, Germany
8Département d’ Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France
9Department of Hematology and Oncology, Saarland University Medical School, Homburg, Germany
10Nottingham University, Nottingham, United Kingdom
11University College London Hospital, Department of Haematology, London, United Kingdom
12Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
13Hematology Department, Institut Paoli-Calmettes, Marseille, France
14Internal Medicine V - Hematology, Oncology & Rheumatology, University of Heidelberg, Heidelberg, Germany

Juan Carlos Hernandez Boluda, MD, PhD1*, Dirk-Jan Eikema2*, Nadia Erazo3*, Nicolaus Kröger, MD4*, Marie Robin, MD, PhD5*, Moniek de Witte6*, Jürgen Finke, MD, PhD7, Alessandro Rambaldi, MD8, Annoek E.C. Broers, MD, PhD9*, Ludek Raida, MD, PhD10*, Nicolaas Schaap11*, Patrizia Chiusolo, MD12*, Mareike Verbeek13*, Goda Choi, MD PhD MBA14, Kazimierz Halaburda15*, Alexander D. Kulagin, MD, PhD16*, Helene Labussiere-Wallet, MD17*, Tobias Gedde-Dahl, MD18*, Werner Rabitsch19*, Kavita Raj20*, Joanna Drozd-Sokolowska21*, Nicola Polverelli, MD, PhD22*, Tomasz Czerw, MD, PhD23*, Ibrahim Yakoub-Agha, MD, PhD24 and Donal P. McLornan, MD, PhD25*

1Hematology Department, Hospital Clínico Universitario, Valencia, Spain
2EBMT Statistical Unit, Leiden, Netherlands
3EBMT Leiden Study Unit, Leiden, Netherlands
4University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
5Hopital Saint Louis, APHP, Université de Paris Cité, Paris, FRA
6UMC Utrecht, Utrecht, Netherlands
7Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
8Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
9Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
10Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
11Department of Hematology, Radboud university medical center, Nijmegen, Netherlands
12Department of Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, NA, Italy
13Klinikum Rechts Der Isar Der TUM, München, Bavaria, DEU
14Dept. of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
15Institute of Hematology and Transfusion Medicine, Warsaw, Poland
16RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation
17Hematology department 1 G, Centre Hospitalier Lyon Sud, Pierre Benite, France
18Rikshospitalet, Clinic for Cancer Medicine, Hematology Dept., Section for Stem Cell Transplantation, Oslo University Hospital, Oslo, Norway
19Internal Medicine I, BMT-Unit, Vienna General Hospital-Medical University of Vienna, Vienna, Austria
20University College London Hospitals NHS Trust, London, United Kingdom
21Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland
22Unit of Blood Diseases and Stem Cell Transplantation, Dpt of Clinical and Experimental Sciences, University of Brescia, ASST-Spedali Civili di Brescia, Brescia, Italy
23Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
24Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, LILLE, France
25DEPARTMENT OF HAEMATOLOGY AND STEM CELL TRANSPLANTATION, UNIVERSITY COLLEGE LONDON HOSPITALS, LONDON, United Kingdom

Yiwen Wang1,2, Junke Wang, MS2*, Ezgi Karaesmen, PhD2, Abbas A. Rizvi, PhD, MS2*, Alyssa I. Clay-Gilmour, PhD3*, Qianqian Zhu, PhD4*, Loreall Pooler5*, Xin Sheng, MS6*, Christopher A. Haiman7*, Amy Webb, PhD8*, Guy Brock, PhD9*, Stephen R. Spellman10*, Philip L. McCarthy, MD11, Marcelo C Pasquini, MD, MS12, Theresa E. Hahn, PhD13 and Lara E. Sucheston-Campbell, PhD, MS2

1Quantitative Sciences Unit, Department of Medicine, Stanford University, Palo Alto, CA
2College of Pharmacy, The Ohio State University, Columbus, OH
3University of South Carolina, Columbia, SC
4Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
5University of Southern California, Los Angeles, CA
6University of Southern California, Keck School of Medicine of USC, Los Angeles, CA
7Keck School of Medicine, Los Angeles, CA
8Department of Biomedical Informatics, The Ohio State University, Columbus, OH
9Ohio State University, Columbus, OH
10CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
11Roswell Park Comprehensive Cancer Center, Buffalo, NY
12CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine,, Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
13Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY

Kordelia Barbullushi, MD1*, Myriam Labopin, MD2,3*, Nicolaus Kröger, MD4*, Jürgen Finke, MD, PhD5, Matthias Stelljes, MD6, Arnold Ganser, MD7*, Wolfgang Bethge, MD8*, Hermann Einsele, MD9, Johannes Schetelig, MD, MSc10, Renato Fanin, MD11*, Pavel Jindra, MD, PhD12*, Jochen Casper, MD, PhD13*, Thomas Schroeder14, Matthias Edinger, MD, PhD15*, Jakob Passweg, MD, MS16, Edouard Forcade, MD, PhD17, Johanna Tischer, MD18*, Arnon Nagler, MD19, Fabio Ciceri, MD20* and Mohamad Mohty, MD PhD3,21,22

1University of Milan, Milan, Italy
2Acute Leukemia Working Party, Paris Study Office, CEREST-TC, European Society for Blood and Marrow Transplantation, Paris, France
3Sorbonne Universités, UPMC Univ Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France
4University Medical Center Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany
5University of Freiburg, Dept. of Medicine-Hematology, Oncology, Freiburg, Germany
6University of Muenster, Dept. of Hematology/Oncology, Muenster, Germany
7Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover, Germany
8Universitaet Tuebingen, Medizinische Klinik, Abteilung II, Tuebingen, Germany
9Universitaetsklinikum Wuerzburg, Med. Klinik und Poliklinik II, Wuerzburg, Germany
10University Hospital, TU Dresden, Medizinische Klinik und Poliklinik I, Dresden, Germany
11Division of Hematology and Stem Cell Transplantation, University Hospital and DAME, Udine, Italy
12Charles University Hospital, Dept. of Hematology/Oncology, Pilsen, Czech Republic
13Klinikum Oldenburg, Abt. Onkologie/Hämatologie, Oldenburg, Germany
14University Hospital, Dept. of Hematology and Stem Cell Transplantation, Essen, Germany
15University Regensburg, Dept. of Hematology and Oncology, Regensburg, Germany
16University Hospital, Hematology, Basel, Switzerland
17CHU Bordeaux, Hôpital Haut-Leveque, Pessac, France
18Klinikum Grosshadern, Med. Klinik III, Munich, Germany
19Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
20Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
21Hematology Department, Hôpital Saint Antoine, Service d'Hématologie Thérapie Cellulaire, Paris, France
22Acute Leukemia Working Party, Paris Study Office, European Society for Blood and Marrow Transplantation, Paris, France

Carmelo Gurnari, MD1,2, Nico Gagelmann3*, Anita Badbaran3*, Hussein Awada1*, Danai Dima, MD1, Simona Pagliuca, MD, PhD4,5, Maud d'Aveni4,5*, Enrico Attardi, MD2*, Raffaella Cerretti, MD2*, Wolschke Christine3*, Marie Thérèse Rubio, MD, PhD6,7*, Jaroslaw P. Maciejewski, MD, PhD, FACP1 and Nicolaus Kröger, MD3*

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy
3University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
4CNRS UMR 7365 IMoPa, Biopôle de l’Université de Lorraine, Vandœuvre-lès-Nancy, France
5Service d'Hématologie Clinique, Hôpital Brabois, CHRU de Nancy, Nancy, France
6Hematology Department, University Hospital of Nancy, Vandoeuvre, France
7IMoPa, University of Lorraine, Vandoeuvre, France

Scott R. Solomon, MD1, Lizamarie Bachier-Rodriguez, MD1*, Xu Zhang, PhD2*, Asad Bashey, MD, PhD1, Lawrence E. Morris Jr., MD1*, H. Kent Holland, MD1 and Melhem Solh, MD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2Center for Clinical and Transitional Sciences, University of Texas Health Science Center, Houston, TX

Gonca Ozcan, MD1, Uday R Popat, MD2, Partow Kebriaei, MD2, Amin M Alousi, MD2, Gheath Alatrash, PhD, DO2, Qaiser Bashir, MD2, Rohtesh S. Mehta, MD2, Jeremy L. Ramdial, MD2, Gabriela Rondon, MD2, Elizabeth J Shpall, MD2, Richard E Champlin, MD2 and Betul Oran, MD, MSc2*

1University of Connecticut Health Center, Farmington, CT
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Maria Chiara Finazzi1,2*, Alessia Civini, BioSc2*, Chiara Pavoni, MSc2*, Anna Grassi, MD2*, Maria Caterina Mico', MD2*, Alessandra Algarotti, MD2*, Marta Bellini, MD2*, Francesca Patriarca, MD, PhD3*, Paola Guglielmelli, MD, PhD4, Mario Luppi5*, Elisa Rumi, MD6,7*, Nicola Polverelli, MD, PhD8*, Giuseppe Messina, MD9*, Stefania Bregante, MD10*, Giuseppe Milone, MD11, Annalisa Imovilli, MD12*, Benedetto Bruno, MD, PhD13*, Maurizio Musso, MD14*, Stella Santarone, MD15, Massimo Pini, MD16, Martina Pennisi17*, Orietta Spinelli, PhD2*, Francesca Bonifazi, MD18*, Alessandro Rambaldi, MD1,2 and Silvia Salmoiraghi, BioSc2*

1Department of Oncology and Hematology, University of Milan, Milan, Italy
2Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
3Hematologic Clinic and Transplant Center, University Hospital of Central Friuli, DAME, University of Udine, Udine, Italy
4CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
5Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy
6Department of Molecular Medicine, University of Pavia, Pavia, Italy
7Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
8Unit of Blood Diseases and Stem Cell Transplantation, Dpt of Clinical and Experimental Sciences, University of Brescia, ASST-Spedali Civili di Brescia, Brescia, Italy
9Azienda Ospedaliera BMM, Reggio Calabria, Italy
10Division of Hematology and Bone Marrow Transplantation, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
11Hematology and BMT Unit, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico-San Marco", Catania, Italy
12Ematologia, Arcispedale S. Maria Nuova Reggio Emilia, Reggio Emilia, Italy
13Division of Hematology, Department of Molecular Biotechnology and Health Sciences, AOU Città della Salute e della Scienza di Torino, Turin, Italy
14U.O.C. OncoEmatologia e TMO, Dipartimento Oncologico, La Maddalena, Palermo, Palermo, Italy
15Ospedale Civile, Pescara, Italy
16Hematology Unit, Ospedale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
17Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
18IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

Amrita Desai, MD1*, Karamjeet S. Sandhu, MD2, Paul B. Koller, MD2, Dongyun Yang, PhD3*, Brian J Ball, MD4, Sally Mokhtari, PhD5, Amanda Blackmon, DO, MS2, Salman Otoukesh, MD2*, Shukaib Arslan, MD2*, Idoroenyi Amanam, MD2, Amandeep Salhotra, MD2, Ahmed Aribi, MD2, Ibrahim Aldoss, MD2, Andrew S. Artz, MD, MS6, Haris Ali, MD2, Anthony S. Stein, MD2, Guido Marcucci, MD2, Stephen J Forman, MD2, Ryotaro Nakamura, MD1*, Michelle Afkhami, MD7* and Monzr M. Al Malki, MD2

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
3Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
4Department of Hematology/HCT, City of Hope National Medical Center, Pasadena, CA
5Department of Clinical Translational Program Development, City of Hope National Medical Center, Duarte, CA
6Department of Hematology/HCT, City of Hope, Duarte, CA
7Department of Pathology, City of Hope National Medical Center, Duarte, CA

Shlomo Elias, MD, PhD1*, Moneeza Walji, MD, BSc, MPH2, Samantha Brown, MS3*, Sean M. Devlin, PhD4*, Esperanza B. Papadopoulos, MD5,6, Ann A Jakubowski, MD PhD5,6, Doris Ponce, MD6,7, James W. Young, MD8, Sergio A Giralt, MD9,10, Miguel-Angel Perales, MD6,11, Brian C. Shaffer, MD5,6, Parastoo B. Dahi, MD6,12, Richard J. Lin, MD6,11, Christina Cho, MD5,6, Roni Tamari, MD6,13, Melody Smith, MD, MS14,15 and Boglarka Gyurkocza, MD5,6

1Adult Bone Marrow Transplant Service/Department of Medicine/Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
5Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Medicine, Weill Cornell Medical College, New York, NY
7MSKCC, New York, NY
8Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY
9Department of Medicine, Weill Cornell Medical College, New York
10Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
11Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
12Memorial Sloan Kettering Cancer Center, New York, NY
13Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
14Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
15Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY

Sergiu Pasca1*, Saurav D. Haldar, MD2, Alexander J. Ambinder, MD, MPH3, Jonathan Webster, MD4*, Tania Jain, MD5, William Brian Dalton, MD, PhD6, Gabrielle T. Prince, MD6*, Gabriel Ghiaur, MD, PhD7, Amy E. DeZern, MD3, Ivana Gojo, MD5, Jonathan Allen Webster, MD8, Cory Schulz9*, Kristin Stokvis, CNP10*, Mark J. Levis, MD11, Richard J. Jones, MD5 and Lukasz P. Gondek, MD, PhD12

1Johns Hopkins University, BALTIMORE, MD
2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
3Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
4The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
6Johns Hopkins Hospital, Baltimore, MD
7Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
8Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
9Johns Hopkins, Baltimore, MD
10Johns Hopkins Hospital, Baltimore
11Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD
12Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

Gabriela Llaurador, MD1, Matthew Willis, MD2*, Michele Redell, MD3*, M Monica Gramatges, MD, PhD4*, Swati Naik, MBBS2, Robert A. Krance, MD5, Erin E Doherty, MD6* and Alexandra McLean Stevens, MD, PhD7

1Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX
2Texas Children's Hospital, Baylor College of Medicine, Houston, TX
3Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX
4Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX
5Department of Pediatrics, Center for Cell and Gene Therapy, Baylor College of Medicine/Texas Children's Hospital/Houston Methodist Hospital, Houston, TX
6Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX
7Department of Pediatric Hematology/Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX

Yumeng Zhang, MD1,2, Jennifer Eatrides, MD3, Ashley Rose, MD4*, Ling Zhang, MD5*, Farhad Khimani, MD6, Aleksandr Lazaryan, MD, PhD, MPH7, Bijal D. Shah, MD3, Hayder Saeed, MD3, Michael D. Jain, MD, PhD8, Hien D. Liu, MD8, Frederick L. Locke, MD4, Javier Pinilla Ibarz, MD3, Jongphil Kim, PhD9*, Mohamed A. Kharfan-Dabaja, MD, MBA10, Ernesto Ayala, MD11, Lubomir Sokol, MD, PhD3 and Taiga Nishihori, MD8

1Moffitt Cancer Center, Tampa, FL
2H. Lee Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Department of Hematopathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
7Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
9Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institutte, Tampa, FL
10Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
11Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL

Ron Ram, MD1, Odelia Amit, MD1*, Shai Winer2*, Yakir Moshe, MD, PhD1*, Pia Raanani, MD3, Eitan Kugler, MD4*, Moshe Yeshurun, MD4*, Irit Avivi, MD1* and Ofir Wolach, MD4*

1BMT Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
4Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Petah –Tikva, Israel

Fengrong Wang, MD1*, Shenmiao Yang1*, Yu Wang2*, Jin Lu, MD3, Kaiyan Liu4 and Xiao-Jun Huang5

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
2Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of HSCT, Peking University, China, Beijing, China
3Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Beijing, China
4Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
5Peking University People’s Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

*signifies non-member of ASH